Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

63 results about "Molecule formation" patented technology

Molecules are formed by combination of atoms or ions by chemically bonding to each other or held by attractive forces due to the charges. A molecule is smallest particle of an element or compound, which is capable of independent existence. If the molecule is made up of atoms of the same element it is said to be homo-atomic.

Rapidly crosslinkable hydrogels with enhanced radiopacity for medical applications

In some aspects, the present disclosure pertains to systems for forming crosslinked reaction products that comprises (a) a first composition that comprises a first multifunctional molecule that comprises a plurality of first reactive moieties that comprise azide groups and (b) a second composition that comprises a second multifunctional molecule that comprises a plurality of second reactive moieties that comprise cyclic alkyne groups, where at least one of the first and second multifunctional molecules is a reactive multi-arm polymer and where at least one of the first and second multifunctional molecules comprises an iodinated core. Other aspects of the present disclosure include crosslinked networks formed from such first and second multifunctional molecules and methods of treatment based on crosslinked networks formed from such first and second multifunctional molecules.
Owner:BOSTON SCIENTIFIC SCIMED INC

Single-molecule device for detecting small-molecule gas based on supramolecules and preparation method of single-molecule device

The invention relates to the technical field of single-molecule devices, in particular to a single-molecule device for detecting small-molecule gas based on supramolecules and a preparation method of the single-molecule device. The monomolecular device comprises a functional molecule and a graphene electrode pair, wherein the functional molecule is connected between the graphene electrode pair through an amido bond. A cucurbituril hydrophobic cavity structure in the functional molecular structural formula can contain and capture target small molecular gas, gas molecules of different volumes are selectively included through multiple weak interaction, a dynamically-adjustable subject-object compound structure is formed, and then switching type sensing detection on the small molecular gas is achieved. The amino terminal of the end part of the main bridging unit in the functional molecule can be connected with the carboxyl terminal of the graphene point electrode in a covalent bond manner, and amide condensation molecular chain connection is formed at the two ends of the graphene point electrode, so that the stability of a monomolecular device is improved. The preparation method provided by the invention is simple in process, mild and controllable in reaction condition and beneficial to large-scale production.
Owner:NANKAI UNIV

SERS / fluorescent bimodal composite probe, preparation method and application thereof, and chiral glucose detection method

The invention belongs to the technical field of biological medicine detection, and particularly relates to an SERS / fluorescent bimodal composite probe, a preparation method and application thereof and a chiral glucose detection method, the composite probe is a gold nanorod modified by a tetraphenylethylene nuclear derivative, and the tetraphenylethylene nuclear derivative is a TPE nuclear molecular probe with AIE attributes; the tetraphenyl ethylene core derivative is prepared by reacting tetrabromo tetraphenyl ethylene with bis (pinacolato) diboron, oxidizing, and reacting with p-mercaptophenylboronic acid. Compared with the prior art, the method has the advantages that the limitations of long time consumption, insufficient sensitivity or specificity deficiency of the traditional chiral molecule identification method in the prior art are solved; and SERS (Surface Enhanced Raman Scattering) and fluorescence analysis are lack of methods and materials suitable for chiral molecule identification. According to the scheme, the composite nanoprobe can form a sandwich structure with molecules of an object to be detected, and rapid detection of chiral glucose is realized according to SERS intensity, fluorescence intensity and color change of the composite nanoprobe.
Owner:SHANGHAI INST OF TECH

Surface-modified doped titanium dioxide nanoparticles and uses

PendingUS20260191744A1Protein moleculesNanoparticle
A titanium dioxide (TiO2) composition and methods of use, the composition containing surface-modified doped TiO2 nanoparticles (sm-TiO2 NPs) disposed in a polymer matrix material, wherein each sm-TiO2 NP has an outer surface having a plurality of bifunctional linker molecules attached thereto and a plurality of protein molecules linked to the sm-TiO2 NP via the bifunctional linker molecules; and wherein the polymer matrix comprises a polymer precursor component.
Owner:THE BOARD OF RGT UNIV OF OKLAHOMA

Hla-a*11:01 short peptides derived from long non-coding rna slc12a5-as1 and use thereof

The application discloses an HLA-A*11:01 renal cell carcinoma tumor antigen short peptide derived from a long-chain non-coding RNA SLC12A5-AS1 and application thereof. The application provides a tumor antigen peptide, and an amino acid sequence of the tumor antigen peptide is shown as SEQ ID No. 1. It is found by the application that a complex formed by the short peptide and a corresponding HLA molecule (HLA-A*11:01) can be recognized by T cells, and an immune response is activated. The application provides a potential target for renal cell carcinoma treatment, and provides a new target screening direction for subsequent tumor antigen treatment of renal cell carcinoma.
Owner:PEKING UNIV +1

Perovskite material, perovskite thin film, optoelectronic device and method of preparation thereof

The application discloses a perovskite material, a perovskite thin film, an optoelectronic device and a preparation method thereof, and the chemical general formula of the perovskite material is A'(A x B 1‑x )Pb n X 3n+1 , wherein A' is at least one of a diamino organic molecule, A is methylamine CH3NH3 + , formamidine CH(NH2)2 + , B is Rb + , X is a halogen ion, x is less than 1, and n is a positive integer. The perovskite material is formed by doping Rb + and a long-chain diamino organic molecule to form an organic-inorganic doped perovskite material, and can be applied to the preparation of a perovskite light-emitting layer in an optoelectronic device such as a light-emitting diode. Based on the introduction of Rb + and the diamino organic molecule in the perovskite material, the working life and stability under a current working state can be effectively prolonged.
Owner:SOUTH CHINA NORMAL UNIV

PD-L1 monoclonal antibody delivery system as well as preparation method and application thereof

The invention discloses a PD-L1 monoclonal antibody delivery system as well as a preparation method and application thereof, and belongs to the technical field of medicines. The preparation method comprises the following steps: coupling amino groups of BPA-PEG9 and a PD-L1 monoclonal antibody through NHS (N-hydroxysuccinimide) esterification to form BPA6-aPDL1; the preparation method comprises the following steps: grafting a glucose derivative maltomimetic acid MA of o-benzene dihydroxyl to a lipid-like amphiphilic molecule PEG (Polyethylene Glycol) (1.5 k-DSPE) through an amido bond to form MA4-PEG (1.5 k-DSPE), namely MA4-PD; then, the BPA6-aPDL1 reacts with the MA4-PD through a boric acid ester bond, and finally, the delivery system MB-aPDL1 is formed. The delivery system not only can successfully deliver the PD-L1 to a tumor site across a blood brain barrier, but also can accurately release the PD-L1 monoclonal antibody, so that the PD-L1 monoclonal antibody is only enriched in a tumor region, the residence time of the antibody is prolonged, the tumor anchoring capability of the antibody is improved, and the occurrence of immune-related adverse events is remarkably reduced.
Owner:SECOND AFFILIATED HOSPITAL OF COLLEGE OF MEDICINEOF XIAN JIAOTONG UNIV

Molecularly imprinted polymers

The present invention relates to molecularly imprinted polymers (MIPs), especially those formed around template molecules with magnetic supports (magnetically supported template molecules). The invention allows magnetically supported template molecules to be recycled and reused in further rounds of MIP production thus significantly increasing MIP yields per unit mass of template molecule. Inventive methodologies for forming the magnetically supported template molecules, in particular their functionalised magnetic precursors, facilitates recycling under very mild conditions which leave the recycled protein template molecules intact, thereby maintaining the quality of MIPs formed therefrom.
Owner:UNIVERSITY OF LANCASHIRE

Three-dimensional printing with supramolecular templated hydrogels

The invention provides a supramolecular polymer composition capable of co-assembly to maintain a three dimensional (3-D) macrostructural form after 3-D printing, made of a solvent, a template molecule; and a reactive component. The reactive component can be at least one monomer that is capable of hydrogen bonding with the template molecule to form a 1D supramolecular structure. The template may be an amphiphilic polymer. The monomer has at least two pendant groups capable of covalent crosslinking. The invention also includes a 3-D structure formed by crosslinking a 3-D printed supramolecular polymer composition, which optionally has a mesoporous structure. Also included is a method of manufacturing a 3-D structure by delivering a supramolecular polymer composition onto a surface of a substrate to form the 3-D structure.
Owner:TRUSTEES OF DARTMOUTH COLLEGE THE

A core-shell structure Fe3O4@PDA@ZIF-67 peroxidase and a preparation method and application thereof

The application relates to the field of nanomaterial structures and analysis sensing technology, and discloses a core-shell structure Fe3O4@PDA@ZIF-67 peroxidase, a preparation method and application thereof. The core-shell structure Fe3O4 nanoparticle is used as a core, the surface of the Fe3O4 nanoparticle is modified by dopamine to form a polydopamine layer, then ZIF-67 is modified on the surface of the Fe3O4@PDA as a shell, and finally the prepared Fe3O4@PDA@ZIF-67 is heat-treated, so that a stable structure is obtained. In the Fe3O4@PDA@ZIF-67 composite material, the ZIF-67 as the shell can adsorb a signal molecule TMB to form a confined reaction, reduce the loss of active oxygen in the catalytic process, improve the sensitivity of the peroxidase-like enzyme applied to hydrogen peroxide sensing analysis, and has certain guiding significance for the structure design of the peroxidase-like enzyme material.
Owner:HUAIYIN INSTITUTE OF TECHNOLOGY

Tissue adhesive material as well as preparation method and application thereof

The invention provides a tissue adhesive material as well as a preparation method and application thereof. The tissue bonding material is prepared from the following raw materials: a polymer monomer, wherein the polymer monomer comprises an acrylic monomer and an acrylamide monomer; the modified chitosan compound is obtained by modifying a chitosan compound through a polyphenol compound, and the polyphenol compound has two or more phenolic hydroxyl groups; and an initiator, wherein the initiator comprises a photoinitiator and a radical initiator. When the tissue bonding material is in contact with a wet or wet tissue surface, interface liquid existing between the bonding material and the wet tissue surface can be quickly absorbed and removed, and carboxyl, amido and catechol groups of the tissue bonding material can form a large number of molecular bonds with molecules on the wet tissue surface, so that instant bonding on the wet tissue surface is formed; and high adhesiveness can be maintained for a long time.
Owner:MEDPRIN REGENERATIVE MEDICAL TECH

Nano-channel based on Pd-Co cyanogen gel nano-enzyme, preparation method and application of nano-channel in glucose detection

The invention discloses a nano-channel based on Pd-Co cyanogen gel nano-enzyme, a preparation method and application of the nano-channel in glucose detection, and belongs to the technical field of biosensors. The nano-channel based on Pd-Co cyanogen glue nano-enzyme is a TiO2 nano-channel (TiNM) with two open ends, the two open ends are a large opening end and a small opening end respectively, metal organic frameworks (MOFs) are grown in situ in the TiNM through a biomimetic mineralization method to immobilize Pd-Co cyanogen glue nano-enzyme molecules, and a metal organic framework composite nano-enzyme structure is formed. Meanwhile, the end face of the small opening end is coated with a pH response polymer to form a gating structure. Glucose generates gluconic acid and hydrogen peroxide under catalysis of Pd-Co cyanogen gel nano-enzyme, the pH change in the channel is triggered, and the pH response polymer is dissolved, so that the gating structure is activated to be opened. The sensor is used for glucose detection, has relatively high selectivity and relatively strong anti-interference capability on glucose, and has good repeatability and operation stability.
Owner:NORTHEASTERN UNIV CHINA

A silicon-based rhodamine compound, a preparation method thereof, a fluorescent modified nucleotide and a kit

The present application relates to the technical field of organic compound reagent, specifically relates to a silicon-based rhodamine compound and a preparation method thereof, fluorescent modified nucleotide and kit, wherein the fluorescent modified nucleotide can be applied to the nucleic acid sequencing reaction of sequencing by synthesis. The present application creatively improves -COR 11 The connection structure between the fluorescent compound dye core structure adopts a heteroalkyl structure containing dioxygen -O-(CH2) m -O-(CH2) n -COR 11 As the connection structure, the connecting group -COR The silicon-based rhodamine compound is connected to the fluorescent compound core structure, and the fluorescence stability, fluorescence intensity and incorporation efficiency of the modified nucleotide formed by the silicon-based rhodamine compound as a modified molecule used in the nucleic acid sequencing reaction are improved.
Owner:SIKUN LIFE SCIENCE CO LTD

Electrochemiluminescence perovskite quantum dot probe with stable aqueous phase and preparation method and application thereof

PendingCN121991685AMaterial nanotechnologyNanoopticsGreen Tea PolyphenolsPhenolic content in tea
The invention discloses an electrochemiluminescence perovskite quantum dot probe with a stable water phase and a preparation method and application thereof. Aiming at the technical bottleneck that the existing perovskite quantum dots are unstable in a water phase and are difficult to be directly used for liquid phase detection, the invention provides a method for preparing an oleylamine / trifluoropropionic acid (OAm / TFPro) double-ligand protected perovskite quantum dot (PQDs) probe by adopting a water phase co-deposition method. The TFPro ligand and water molecules form a hydrogen bond interface through a fluorine-containing group of the TFPro ligand, and a protective layer is constructed on the surfaces of the PQDs, so that the PQDs can be stably dispersed in a water phase for a long time, and efficient electrochemical luminescence (ECL) activity is maintained. An ECL sensing platform constructed based on the probe realizes high-sensitivity and high-selectivity detection of tea polyphenol in tea leaves, and has the advantages of wide linear range, low detection limit, strong anti-interference capability and the like. The method is simple in process and low in cost, and a novel efficient detection tool is provided for the field of food quality safety.
Owner:YANCHENG INST OF TECH

Rapidly crosslinkable hydrogels with enhanced radiopacity for medical applications

PCT designated stage expiredWO2025128867A1X-ray constrast preparationsIntravenous devicesMoietyAlkyne
In some aspects, the present disclosure pertains to systems for forming crosslinked reaction products that comprises (a) a first composition that comprises a first multifunctional molecule that comprises a plurality of first reactive moieties that comprise azide groups and (b) a second composition that comprises a second multifunctional molecule that comprises a plurality of second reactive moieties that comprise cyclic alkyne groups, where at least one of the first and second multifunctional molecules is a reactive multi-arm polymer and where at least one of the first and second multifunctional molecules comprises an iodinated core. Other aspects of the present disclosure include crosslinked networks formed from such first and second multifunctional molecules and methods of treatment based on crosslinked networks formed from such first and second multifunctional molecules.
Owner:BOSTON SCIENTIFIC SCIMED INC

Hierarchical structure-property alignment method for molecule generation and editing

The embodiment of the invention provides a hierarchical structure-property alignment method for molecule generation and editing, and belongs to the technical field of computational chemistry, and the hierarchical structure-property alignment method specifically comprises the following steps: obtaining SMILES representation and property representation; the SMILES representation is extracted into three levels, the property representation is extracted into two levels, and InfoNCE contrast loss is calculated; based on the potential variables and the property characterization, obtaining fusion characterization through a bidirectional cross attention mechanism; constructing an example set based on a molecular skeleton clustering method, screening difficult example molecules to form a challenge set by using reconstruction loss of an auxiliary variational auto-encoder, and gradually introducing challenge set samples by adopting a progressive sampling strategy; constructing a joint training target, and training the model from end to end; after model training is completed, diversified molecular candidates are generated or molecular property modification is carried out. Through the scheme disclosed by the invention, the accuracy and the stability of multi-property molecule editing are improved.
Owner:CENT SOUTH UNIV

Method for rapidly screening active pharmaceutical ingredients based on competitive ultrafiltration technology

The invention belongs to the field of traditional Chinese medicine natural active ingredient analysis and medicine discovery, and particularly relates to a method for rapidly screening medicine active ingredients based on a competitive ultrafiltration technology. Based on the principle of'target site occupation competition ', the replacement effect of a high-activity inhibitor on a low-activity inhibitor is utilized to directionally capture a potent inhibitor. In the incubation process, the small molecule compound is combined with an enzyme active center to form an enzyme-ligand compound. Most of the enzyme-ligand compound forming processes are reversible, and molecules with relatively strong activity have relatively strong binding force with an enzyme active center, so that molecules with relatively weak activity can be replaced, and a new enzyme-ligand compound is formed. Based on this, a competitive ultrafiltration technology is proposed.
Owner:THE AFFILIATED HOSPITAL OF SHANDONG UNIV OF TCM

Preparation method and application of multistage rocket structure nano material

The invention discloses a preparation method and application of a multistage rocket structure nanometer material in the technical field of biomedical materials. Mesoporous silicon dioxide (MSNs) serves as a core, gemcitabine (GEM) is wrapped in the core, the outer layer of the core is coated with calcium carbonate to form a middle layer, halofuginone (HF) is loaded on the middle layer, and the outermost layer is connected with targeting molecules to form a core-shell structure; the nano material has pH and GSH dual responsiveness, calcium carbonate on the outer layer is disintegrated in a subacid environment with the pH being 6.2-6.5, and mesoporous silica (MSNs) on the inner layer is further disintegrated in a 10mM GSH environment; the synthesis method provided by the invention is simple and easy to operate, and the nanoparticles have the advantages of large specific surface area, uniform particle size, good biocompatibility and the like.
Owner:河清(深圳)医学研究有限公司

Functionalized bioactive glass as well as preparation method and application thereof

The invention discloses functional bioactive glass as well as a preparation method and application thereof, and relates to the technical field of regenerative medical materials.The functional bioactive glass provided by the invention takes silicon, calcium, phosphorus and sodium as basic components, a porous structure is constructed by introducing nano zinc oxide (ZnO), and hydrophilicity and dispersity are improved by utilizing short amylose surface grafting. The nano zinc oxide is used as a pore-forming template and is selectively dissolved out in the subsequent steps to form sphere-like pores with the pore diameter of 1-30nm and the porosity of 30-70%, so that physical support is provided for cell adhesion and bone tissue ingrowth. The short amylose is grafted on the surface of the glass through a covalent bond of an amino silane coupling agent, and hydroxyl (-OH) on a molecular chain of the short amylose and water molecules form a hydrogen bond, so that the contact angle of the material is obviously reduced, and particle aggregation is effectively inhibited.
Owner:CHONGQING INNOVIT REGENERATIVE MEDICINE TECHNOLOGY CO LTD

Computer program, information processing apparatus, information processing method, and learning model generation method

To provide a computer program, an information processing device, an information processing method, and a learning model generation method capable of performing calculation of interaction between molecules faster than quantum chemical calculation.SOLUTION: The computer program causes a computer to execute a process of acquiring a feature value of a complex and a molecule contained in the complex, acquiring a molecular formation energy of the complex and the molecule contained in the complex output by a learning model by inputting the acquired feature value to the learning model that outputs the molecular formation energy of the complex and the molecule contained in the complex when the feature value of the complex and the molecule contained in the complex is input, and estimating an interaction energy between the molecules contained in the complex based on the acquired molecular formation energy.SELECTED DRAWING: Figure 1
Owner:KYOTO UNIV

Use of compound a and derivatives thereof for the preparation of radiopharmaceuticals

PendingCN122297734ACompound aPharmacy medicine
This invention relates to the application of compound A and its derivatives in the preparation of radiopharmaceuticals. The inventors discovered that compound A forms a chelated ligand compound with a target molecule via a linker, which then interacts with the radionuclide. 9 Zr、 47 Sc、 55 Co、 60 Cu、 61 Cu、 62 Cu、 64 Cu、 67 Cu、 66 Ga、 67 Ga、 68 Ga、 82 Rb、 86 Y、 87 Y、 90 Y、 97 Ru、 105 Rh、 109 Pd, 111 In、 117m Sn、 149 Pm, 52 Mn, 149 Tb, 152 Tb, 161 Tb, 99m Tc, 153 Sm、 177 Lu、 186 Re、 188 Re、 199 Au、 201 Tl、 203 Pb, 210 Pb, 212 Pb, 212 Bi、 213 Bi、 225 Ac、 223 Ra and 227 Th can form stable chelates labeled with radioactive metal nuclides under conditions without heating or low temperature. This chelation reaction is highly efficient, and the purity of the chelated product is greater than 95%. Furthermore, the resulting nuclide chelate derivatives exhibit low toxicity and good metabolic properties in vivo, indicating high clinical pharmaceutical potential.
Owner:NANJING THERANOSTA INC

HLA-A*11:01 renal cell carcinoma tumor antigen short peptide derived from long noncoding RNA LINC02717

The application discloses an HLA-A*11:01 renal cell carcinoma tumor antigen short peptide derived from a long-chain non-coding RNA LINC02717. The application provides a tumor antigen peptide, and the amino acid sequence of the tumor antigen peptide is shown as SEQ ID No. 1. The application finds that the complex formed by the short peptide and a corresponding HLA molecule (HLA-A*11:01) can be recognized by T cells, and an immune response is activated. The application provides a potential target for renal cell carcinoma treatment, and provides a new target screening direction for subsequent tumor antigen treatment of renal cell carcinoma.
Owner:PEKING UNIV +1

Tissue phase homogenizing agent as well as preparation method and application thereof

PendingCN120919401ATissue regenerationProsthesisSwelling ratioPolyvinyl alcohol
The invention provides a tissue phase homogenizing agent and a preparation method and application thereof, and belongs to the technical field of biological tissue engineering, the homogenizing agent is composed of hydrophilic matrixes (glucose, polyglycerol, poloxamer F127 and polyvinyl alcohol), functional additives (mannose, N-acetylcysteine, sodium hyaluronate and polyethylene glycol) and ultrapure water, and the pH value is 7.0 + / -0.2. Hydrophilic groups and water molecules form a hydrogen bond network, a continuous hydration layer is constructed on a phase interface, phase domain fusion, refractive index homogenization and molecular ordering are achieved, the problem of biological tissue phase homogenization is solved, tissue light transmittance can be improved, the swelling ratio can be stabilized, and the hydrogel has cell proliferation promoting activity and is suitable for tissue transplantation operation and bioengineering tissue preservation.
Owner:GUANGZHOU PUDAO LIANXIN BIOTECH CO LTD

A single-molecule chain pH sensor based on a graphene electrode and a preparation method thereof

The present invention relates to the field of semiconductor technology, and particularly to a single-molecule chain pH sensor based on a graphene electrode and a preparation method thereof. The pH sensor includes a graphene source electrode, a single-molecule chain, and a graphene drain electrode sequentially connected by an amide bond; the single-molecule chain includes a starting unit, a single-molecule polymer, and a termination unit connected in sequence. The starting unit and the termination unit are selected from aniline or phenylenediamine, and the single-molecule polymer is formed by electrochemically polymerizing monomer molecules. The monomer molecules are selected from aniline or aniline derivatives. The electrochemically polymerization method enables the polymerization process of the monomer molecules to be controllable, combines static electrodes with dynamic assembly, and can optimize the performance of the pH sensor; at the same time, the electrochemically polymerization method can significantly improve the size adaptability between the single-molecule chain and the static graphene electrode by flexibly adjusting the number of monomer molecules during the dynamic assembly process, thereby improving the connection success rate.
Owner:NANKAI UNIV

Nucleic acid molecule delivery carrier as well as preparation method and application of freeze-drying preparation of nucleic acid molecule delivery carrier

The invention discloses a nucleic acid molecule delivery carrier as well as a preparation method and application of a freeze-drying preparation of the nucleic acid molecule delivery carrier. Wherein the delivery vehicle comprises a nucleic acid molecule encoding interleukin 12 and an ionizable lipid compound. According to the invention, the mRNA of the interleukin 12 with an optimized sequence is used, the mRNA is more stable, the protein expression is increased, and the misfolding rate is reduced. Meanwhile, the interleukin 12 is anchored through a transmembrane sequence, so that the possible immune storm risk is reduced. Besides, on the basis of newly synthesized, degradable and novel ionizable lipid molecules, a high-efficiency and low-toxicity freeze-drying preparation delivery system based on lipid is formed, and the freeze-drying preparation has potential application value in the fields of preventive vaccines and therapeutic drugs.
Owner:BEIJING TRICISIONBIO THERAPEUTICS INC

Label, marker and method for analyzing a biological sample

A label for analyzing a biological sample includes a first label part comprising a first nucleic acid backbone, and a second label part comprising a second nucleic acid backbone. The first nucleic acid backbone and the second nucleic acid backbone are configured to hybridise at least partially to each other. The label further includes at least one first labelling moiety and at least one second labelling moiety, and at least one guest molecule configured to form a complex with a host molecule.
Owner:LEICA MICROSYSTEMS CMS GMBH +1

Thawing fluid, preparation method therefor and use thereof

A thawing solution has 0.1-50 g of a biomimetic material for controlling ice, 0-1.0 mol L−1 of a water-soluble sugar, and balance of a buffer solution. The biomimetic material for controlling ice is a material for controlling ice having an ice-philic group and a hydrophilic group. The hydrophilic group is a functional group that can form a non-covalent interaction with water molecules, and the ice-philic group is a functional group that can form a non-covalent interaction with ice. Using the thawing solution and the thawing reagent prepared from the biomimetic material for controlling ice, which material has ice-philic and hydrophilic properties, the growth and recrystallization of ice crystals can be effectively controlled, and damage to cells or tissue caused by uncontrolled growth of the ice crystals during recovery can be significantly ameliorated.
Owner:PEKING UNIVERSITY THIRD HOSPITAL (THE THIRD CLINICAL MEDICAL SCHOOL OF PEKING UNIVERSITY) +1

Method for screening molecules of interest capable of forming complexes with plurality of types of target molecules, and method for producing molecules of interest including screening method

The present invention relates to a method of screening for a molecule of interest, comprising: (1) a step of preparing a linked construct by linking a plurality of kinds of target molecules to each other, or linking one or more kinds of target molecules and a candidate molecule-nucleic acid conjugate (linking step); and (2) a step of contacting the linked construct in which the plurality of kinds of target molecules are linked to each other with a candidate molecule-nucleic acid conjugate, or contacting the linked construct in which the one or more kinds of target molecules and the candidate molecule-nucleic acid conjugate are linked with a target molecule that is not used in the linking step (contacting step).
Owner:CHUGAI PHARMA CO LTD